Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

October 22, 2021

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Fetal Alcohol Spectrum Disorders
Interventions
DRUG

Choline Bitartrate

Powdered drink mix for daily consumption

Trial Locations (1)

55454

University of Minnesota, Minneapolis

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Jeff Wozniak

OTHER